Xcene Research Corporate Fact Sheet
Xcene Research Overview: Xcene Research is a full-service Contract Research Organization (CRO) specializing in clinical trial management across Sub-Saharan Africa. We are committed to finding innovative global health solutions through clinical research by leveraging extensive therapeutic experience, internal capacity, and infrastructure development. Xcene Research prioritizes local partnership and capacity building to strengthen Africa’s emerging sector, ensuring ethical and quality-focused conduct aligned with international standards.
- Corporate Identity: Founding Year, 2015
- Headquarters/Registration: Operational Hubs Lagos, Nigeria (HQ); Registered in the US and Nigeria
- Service/Operational Scope: Primary Function Full-service Clinical Trial Management Organization (CRO) in Sub-Saharan Africa (Operational Footprint, Nigeria, Ghana, Kenya, Uganda, Zambia)
- African Market Gap: Global Trial Share, Africa conducts <3 of global trials (despite 18% of global population)
- Xcene Research Initiatives: SCD trials (GBT/Pfizer: Vox Inclaumab, Osivelotor/ Novatis Trials: Crizanlizumab/ SickleGenAfrica: Genomics-focused/ Novo Nordisk Trials: HIBISCUS, NDec trials/Agios trials: RISE UP study/ Fulcrum Trial: PIONEER study)
- Nigerian Policy Alignment: PVAC Initiative Target. Nigeria aims for 437 trial centers by 2028, generating $3.8 billion in revenue and 500,000 jobs
- Regulatory Driver: NAFDAC Bio-equivalence Mandate, NIMR, NIPRD, NHREC, etc.
- Key Thought Leadership: Flagship Event, Impact Africa Summit (IAS) (Link to the IAS website)
Press Releases and Media Appearances:
- Xcene Research Reveals Central Theme for Impact Africa Summit 6.0
- Xcene Research Urges Stronger Clinical Trial Capacity for Africa’s Health Autonomy
- Organisation Urges Africa to Strengthen Clinical Trials to Attain Health Autonomy
- Impact Africa Summit 6.0: Amplifying African Voices in Clinical Trials
- Xcene Research Advocates Expanded Clinical Trials in Sub-Saharan Africa
- NAFDAC, NIMR, partner research firm to transform clinical studies – Healthwise
- Impact Africa Summit 2024 to Position Sub-Saharan Africa as Clin
- Pharmaceutical summit to address health sector problems
- Harnessing the momentum of world sickle cell advocacy day for real change in Nigeria
Media contact: info@xceneresearch.com
Phone Number: 08055559546
